๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy of bezafibrate in a patient with primary sclerosing cholangitis

โœ Scribed by Takeshi Kurihara; Atsushi Maeda; Mutsuo Shigemoto; Katsuko Yamashita; Naoyuki Kamatani


Publisher
Springer Japan
Year
2003
Tongue
English
Weight
119 KB
Volume
38
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cancer surveillance in patients with pri
โœ Nataliya Razumilava; Gregory J. Gores; Keith D. Lindor ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 274 KB ๐Ÿ‘ 2 views

Primary sclerosing cholangitis (PSC) is a chronic fibroinflammatory syndrome involving the biliary tract, often accompanied by inflammatory bowel disease (IBD). This syndrome is a prototype disease linking chronic inflammation to carcinogenesis. Indeed, PSC is associated with an increased risk of ch

Advances in the diagnosis of cholangioca
โœ Laura E. Moreno Luna; Gregory J. Gores ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 170 KB ๐Ÿ‘ 1 views

Primary sclerosing cholangitis (PSC) is an idiopathic chronic cholestatic liver disease characterized by inflammatory destruction of the biliary tree. It slowly progresses, resulting in biliary fibrosis and obliteration leading to end-stage liver disease. The most feared complication of PSC is the d

Prevalence and predictors of esophageal
โœ Claudia O. Zein; Keith D. Lindor; Paul Angulo ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 148 KB ๐Ÿ‘ 2 views

Patients with primary sclerosing cholangitis (PSC) may develop and bleed from esophageal varices. However, the exact prevalence of esophageal varices in patients with PSC remains unknown and potential predictors of esophageal varices in this population have not been identified. Our aim was to determ